← Back
$AKRO All transactions

Akero Therapeutics, Inc.

▼ SELL

$ Value

$47K

Shares

848

Price

$55

Filed

Jun 20

Insider

Name

Gangloff Scott A.

Title

Chief Technology Officer

CIK

0001663253

Roles

Officer

Transaction Details

Transaction Date

2025-06-18

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

23,452

Footnotes

Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. Such sales were automatic and not at the discretion of the Reporting Person. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $54.73 to $54.84, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Filing Info

Accession No.

0000950170-25-088640

Form Type

4

Issuer CIK

0001744659

Gangloff Scott A.'s History

Date Ticker Type Value
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-08-15 AKRO M $51K
2025-08-15 AKRO M $0
2025-06-30 AKRO A $7K
2025-06-18 AKRO $47K

Other Insiders at AKRO (90d)

No other insider activity at this issuer in the last 90 days.